Autoimmune diseases make the immune system attack healthy tissues. These can affect organs like kidneys, leading to ...

Research shows multiple factors drive CKD risk in lupus nephritis, including nephritic flares, baseline hypertension, renal ...

Lupus nephritis is a serious complication of lupus — and because it doesn’t always cause symptoms right away, it’s important to find it early. Talk to your lupus doctor about getting screened (tested) ...

A letter from the veterinarian's office that euthanized one of the 32 dogs in Cheshire Animal Control's care describes the ...

A regulatory decision is expected by October 2025. The Food and Drug Administration (FDA) has accepted the supplemental Biologics License Application (sBLA) for obinutuzumab (Gazyva ®) for the ...

Kyverna Therapeutics (NASDAQ:KYTX – Get Free Report) is expected to be issuing its quarterly earnings data before the market opens on Tuesday, March 25th. Analysts expect the company to announce ...

Having established success in cancer, biopharma is now looking to leverage CAR T therapies against a new target, autoimmune ...

Shares of Artiva Biotherapeutics, Inc. (NASDAQ:ARTV – Get Free Report) have received a consensus rating of “Buy” from the six ratings firms that are covering the company, MarketBeat.com reports. Six ...

Artiva Biotherapeutics, Inc.’s ARTV share price has surged by 15.10%, which has investors questioning if this is right time to sell.

Chronic kidney disease is a permanent, progressive and irreversible deterioration of renal function in which the person ...

With nearly 2 lakh new cases of kidney failure diagnosed annually in India, Chronic Kidney Disease is a growing health ...